Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Neuromodulation company electroCore completes $40mm Series A financing; adds $10mm
01 Jul 2014
ElectroCore LLC, which is targeting nerve signal imbalances via neuromodulation, completed a $40mm Series A financing from Merck Global Health Innovation LLC (operated by Merck & Co. Inc.) and private equity firms Easton Capital and Core Ventures II.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?